Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. - Chung J; Vallurupalli M; Noel S; Schor G; Mrowka S; Scapozza I; Demere Z; Kammula SV; Hu M; Kim SY; Liu Y; Nobrega C; et al. (Science (New York, N.Y.), 2026)